The Study
Effectiveness of an app-based walking program for obese patients with inflammatory bowel disease in Korea: a single-blind parallel-group randomized clinical trial
This study is like a fair test where one group got a walking app with reminders and videos, and another group got the same app but no extra help. The group with extra help lost more fat and felt less stressed, but we can't say for sure the app caused it because both groups had the same gadgets. It's good evidence, but not perfect.
Analysis score
Maximum 90 for a randomized controlled trial.
Where the score came from
This study tested if a phone app that reminds you to walk and gives you fun challenges helps people with IBD and extra weight lose body fat.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 573 / 100
Quality score
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Losing 2% body fat and 0.8 BMI points in 10 weeks is meaningful for health — it lowers inflammation and disease risks, even if muscle didn't grow or IBD symptoms didn't improve yet.
- 2People using the app with tips and rewards walked 3,144 more steps per day, lost 0.8 points off their BMI, and lost 2.1% body fat.
- 3Their stress and fatigue went down, but so did the control group's.
- 4Muscle mass and IBD quality of life didn't change.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
BMC Gastroenterology
Year
2025
Authors
Young Jin Lee, E. Kwon, Da-In Park, S. Park, S. Hwang, B. Ye
Related Content
Claims (4)
A 10-week walking program using a mobile app did not improve disease-specific quality of life in obese adults with inflammatory bowel disease, even though it improved body composition and psychological symptoms.
In obese adults with inflammatory bowel disease, a 10-week walking program using a mobile app did not increase skeletal muscle mass, even though it reduced body fat and body mass index.
Obese adults with inflammatory bowel disease who followed a 10-week walking program of 7,000 steps per day on at least five days per week experienced a reduction in body mass index by 0.8 kg/m² and a decrease in body fat percentage by 2.1%, compared to those who received no structured behavioral support.
In obese adults with inflammatory bowel disease, a 10-week walking program using an app led to small reductions in perceived stress and fatigue, but these changes were not greater than those seen in people who used the same app without any special walking instructions.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.